Immunovant
(NASDAQ) IMVT
Immunovant Financials at a Glance
Market Cap
$8.28BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$505.61M
EPS (TTM)
-$2.77
P/E Ratio
-14.55
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$40.85
Volume
12,558
Open
$40.58
Price
$40.85
Volume
12,558
Open
$40.58
Previous Close
$40.31
Daily Range
$40.49 - $41.19
52-Week Range
$14.32 - $41.19
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$40.85
Volume
12,558
Open
$40.58
Previous Close
$40.31
Daily Range
$40.49 - $41.19
52-Week Range
$14.32 - $41.19
Estimated Earnings Date
Aug 10, 2026
IMVT News
IMVT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Immunovant
Industry
Biotechnology
Sector
Health CareEmployees
315
CEO
Eric Venker, MD, PharmD
Website
www.immunovant.comHeadquarters
New York City, NY 10018, US
IMVT Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-68.16%
Return on Capital
-62.50%
Return on Assets
-52.83%
Earnings Yield
-6.87%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.28BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
205.31M
Volume
12.56K
Avg. Volume
1.94M
Financials (TTM)
Gross Profit
-$206.00K
Operating Income
-$532.90M
EBITDA
-$504.98M
Operating Cash Flow
-$407.31M
Capital Expenditure
-$8.00K
Free Cash Flow
-$407.32M
Cash & ST Invst.
$902.11M
Total Debt
$72.00K
Immunovant Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$8.28BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$22.86M
N/A
Employees
362
N/A
Net Income
-$147.86M
-38.9%
EBITDA
-$150.60M
-42.4%
Quarterly Fundamentals
Total Cash
$902.11M
+26.4%
Total Debt
$72.00K
-26.5%
Accounts Receivable
$3.95M
+57.1%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$72.00K
-26.5%
Return on Assets
-52.83%
N/A
Return on Invested Capital
-62.50%
N/A
Free Cash Flow
-$95.07M
+14.2%
Operating Cash Flow
-$95.06M
+14.1%